Skip to content

Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Pulse Rate

Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Pulse Rate

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05640323
Enrollment
37
Registered
2022-12-07
Start date
2023-04-26
Completion date
2023-10-20
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Healthy

Keywords

medical device, validation, arrhythmia, ECG, pulse rate, Norbert Device, Norbert Health

Brief summary

The study will evaluate the mean average error (MAE) of measuring pulse rate using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).

Detailed description

The study design is to validate the pulse and heart rate accuracy as required per ISO 80601-2-61, Clause 201.12.1.104. The study is a non-randomized, non-blinded single arm design to evaluate the clinical accuracy of the ND's pulse rate measurement compared to a reference heart rate manually measured by observing R-peaks in a standard concurrently recorded ECG from an FDA 510(k)-cleared reference clinical ECG (RCECG). The sponsor will ensure that the study staff enrolls a range of types of arrhythmias including tachycardia, bradycardia, atrial fibrillation, bigeminy, trigeminy, and others.

Interventions

The Norbert Device (ND) is a contactless, noninvasive device that provides measurements of body temperature, oxygen saturation (SpO2), and pulse rate.

Sponsors

Northwell Health
CollaboratorOTHER
Norbert Health
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female subjects aged 18 or over * Ability to provide signed informed consent

Exclusion criteria

* Pregnant * Otherwise deemed unsuitable to participate in the study based on judgment of the study investigator

Design outcomes

Primary

MeasureTime frameDescription
Mean Average Error (MAE)Up to 1 hourMAE will be evaluated by Mean absolute error (MAE) of the pulse rate of the device compared to the heart rate measured from the RCECG.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026